List of Excipients in API famotidine, calcium carbonate and magnesium hydroxide
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing famotidine, calcium carbonate and magnesium hydroxide
Detailed excipient profiles for famotidine, calcium carbonate and magnesium hydroxide
Excipient focus: ANHYDROUS LACTOSE
famotidine, calcium carbonate and magnesium hydroxide drug variants containing ANHYDROUS LACTOSE
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ASPARTAME
famotidine, calcium carbonate and magnesium hydroxide drug variants containing ASPARTAME
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing ASPARTAME
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
famotidine, calcium carbonate and magnesium hydroxide drug variants containing CELLULOSE, MICROCRYSTALLINE
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 7
famotidine, calcium carbonate and magnesium hydroxide drug variants containing D&C RED NO. 7
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing D&C RED NO. 7
| Company | Ingredient | NDC |
|---|---|---|
| Walgreen Company | famotidine, calcium carbonate and magnesium hydroxide | 0363-0321 |
| Wakefern Food Corporation | famotidine, calcium carbonate and magnesium hydroxide | 41190-003 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTRATES
famotidine, calcium carbonate and magnesium hydroxide drug variants containing DEXTRATES
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing DEXTRATES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
famotidine, calcium carbonate and magnesium hydroxide drug variants containing FD&C BLUE NO. 1
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
famotidine, calcium carbonate and magnesium hydroxide drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Safeway | famotidine, calcium carbonate and magnesium hydroxide | 21130-614 |
| Target Corporation | famotidine, calcium carbonate and magnesium hydroxide | 82442-321 |
| >Company | >Ingredient | >NDC |
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C RED NO. 40
famotidine, calcium carbonate and magnesium hydroxide drug variants containing FD&C RED NO. 40
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C RED NO. 40 ALUMINUM LAKE
famotidine, calcium carbonate and magnesium hydroxide drug variants containing FD&C RED NO. 40 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Safeway | famotidine, calcium carbonate and magnesium hydroxide | 21130-614 |
| Target Corporation | famotidine, calcium carbonate and magnesium hydroxide | 82442-321 |
| >Company | >Ingredient | >NDC |
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing FD&C RED NO. 40 ALUMINUM LAKE
Excipient focus: GLYCERYL MONOSTEARATE
famotidine, calcium carbonate and magnesium hydroxide drug variants containing GLYCERYL MONOSTEARATE
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
famotidine, calcium carbonate and magnesium hydroxide drug variants containing LACTOSE MONOHYDRATE
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
famotidine, calcium carbonate and magnesium hydroxide drug variants containing MAGNESIUM STEARATE
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
famotidine, calcium carbonate and magnesium hydroxide drug variants containing POLYSORBATE 80
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
famotidine, calcium carbonate and magnesium hydroxide drug variants containing POVIDONE
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Wakefern Food Corporation | famotidine, calcium carbonate and magnesium hydroxide | 41190-003 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONES
famotidine, calcium carbonate and magnesium hydroxide drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Wakefern Food Corporation | famotidine, calcium carbonate and magnesium hydroxide | 41190-003 |
| >Company | >Ingredient | >NDC |
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing POVIDONES
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
famotidine, calcium carbonate and magnesium hydroxide drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Safeway | famotidine, calcium carbonate and magnesium hydroxide | 21130-614 |
| Target Corporation | famotidine, calcium carbonate and magnesium hydroxide | 82442-321 |
| >Company | >Ingredient | >NDC |
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Excipient focus: STARCH, CORN
famotidine, calcium carbonate and magnesium hydroxide drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Amerisource Bergen | famotidine, calcium carbonate and magnesium hydroxide | 24385-201 |
| >Company | >Ingredient | >NDC |
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing STARCH, CORN
Excipient focus: TALC
famotidine, calcium carbonate and magnesium hydroxide drug variants containing TALC
famotidine, calcium carbonate and magnesium hydroxide drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links